BBH ETF: VanEck Biotech ETF - Price, Holdings & Analysis
VanEck Biotech ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About VanEck Biotech ETF
What is the current price of BBH?
The latest BBH price is $206.25. The 52-week range is $154.75–$212.54. BBH has returned 30.9% over the past 52 weeks.
What is the expense ratio for BBH?
BBH's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BBH pay dividends?
Yes, BBH pays a 0.47% dividend yield. The last ex-dividend date was 2026-12-26. View full dividend history in the Dividends section.
What are the top holdings of BBH?
BBH's largest holdings are Amgen Inc. (14.5%), Gilead Sciences, Inc (14.3%), Vertex Pharmaceuticals Incorporated (8.1%) (combined weight: 36.9%). The fund holds 25 total positions. View the complete portfolio breakdown in the Holdings section.
How does BBH compare to similar ETFs?
Compare BBH (0.35% expense ratio, $366M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.